From: Prolonged outbreak of Serratia marcescens in Tartu University Hospital: a case–control study
Characteristic | Case patients (n= 105) | Control patients (n= 206) | OR | CI95 |
---|---|---|---|---|
Mean gestational age, wk | 34 | 37 | 0,76* | 0,69–0,83 |
(range; OR per week) | (23–41) | (25–42) | ||
Mean birth weight, g | 2235 | 2986 | ||
(range; OR per 500g) | (500–5220) | (400–5850) | 0,56* | 0.6–0.68 |
Vaginal delivery | 50 (48%) | 132 (64%) | ||
Cesarean section | 55 (52%) | 74 (36%) | 1,92* | 1.18–3.12 |
Apgar score after 1 min | 6 | 7 | 0,84* | 0.75–0.93 |
Prematurity | 75 (71%) | 74(36%) | 5.46* | 3.01–9.93 |
Invasive device | ||||
Intubation | 35 (33%) | 27 (13%) | 2,18* | 1,55–8,43 |
Mean duration of intubation, d | 8,1 | 3,7 | ||
(range) | (1–61) | (1–24) | 1,06 | 0,93–1,22 |
CVC | 31 (30%) | 31 (15%) | 2,87* | 1,51–5,46 |
Mean duration of CVC,d | 10 | 7,4 | ||
(range) | (1–42) | (1–30) | 1,08* | 1,02–1,13 |
Arterial catheter | 51 (49%) | 45 (22%) | 10,44* | 4,06–26,83 |
Peripherial catheter | 102 (97%) | 160 (78%) | 10,18* | 3,09–33,53 |
Nasogastral tube | 86 (82%) | 88 (43%) | 6,86* | 3,57–10,07 |
Parenteral feeding | 28 (27%) | 25 (12%) | 4,72* | 2,27–9,8 |
Breast milk | 77 (73%) | 179 (87%) | 0,37* | 0,19–0,71 |
Antimicrobial therapy | 93 (89%) | 100 (51%) | 10,86* | 4,63–25,46 |
Mean duration of antimicrobial therapy, d | 7,5 | 6,5 | 1,03 | 0,98–1,08 |
(range) | (1–52) | (1–29) | ||
Maternal infection | 21 (20%) | 45 (24%) | 0,84 | 0,46–1,53 |
Mean length of stay, d | 31 | 13 | 1,05* | 1,03–1,07 |
(range) | (3–213) | (2–90) | ||
Surgery | 14 (13%) | 11 (5%) | 2,72* | 1,16–6,37 |
Outcome (death) | 4 (4%) | 3 (2%) | 3,61 | 0,65–19,91 |